56.78
2.04 (3.73%)
2.04 (3.73%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Arrowhead Pharmaceuticals Inc | ARWR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 2.04 | 3.73% | 56.78 | 19:58:54 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 56.72 | 54.4213 | 58.50 | 54.79 | 54.74 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 56.80 | 58.78 | 1.98 | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 21,270 | 2,048,278 | $ 56.89 | $ 116,521,974 | 2,190,041 | 19.5101 - 74.40 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:55:43 | formt | 147 | $ 56.78 | USD |
Arrowhead Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 5.81B | 102.29M | 74.24M | $ 168.80M | $ -75.87M | 0.69 | -76.55 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | 6.00% |
Arrowhead Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ARWR Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 46.27 | 58.50 | 44.29 | 49.92 | 1,909,556 | 10.51 | 22.71% |
| 1 Month | 43.60 | 58.50 | 42.40 | 47.06 | 1,207,423 | 13.18 | 30.23% |
| 3 Months | 45.77 | 58.50 | 32.86 | 44.40 | 1,490,589 | 11.01 | 24.06% |
| 6 Months | 37.72 | 58.50 | 30.83 | 41.80 | 1,301,477 | 19.06 | 50.53% |
| 1 Year | 36.37 | 74.40 | 19.5101 | 45.59 | 1,636,439 | 20.41 | 56.12% |
| 3 Years | 3.88 | 74.40 | 3.01 | 25.54 | 1,699,261 | 52.90 | 1,363.4% |
| 5 Years | 5.20 | 74.40 | 1.20 | 19.54 | 1,405,986 | 51.58 | 991.92% |
Arrowhead Pharmaceuticals Description
| Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease. |
